Skip to Main Content

Paper Details

High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors.
J Neurooncol
0
2022
Author NameAffiliation
Robert A OsterO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham
Robert A OsterUniversity of Alabama at Birmingham
  • 1 - 2

Datasets

Release 1.2